Story
Regenxbio Shares Surge After Director Purchases Over $950,000 in Stock
Shares of Regenxbio Inc. (NASDAQ: RGNX) rose 7.1% in premarket trading on Friday following the disclosure of significant insider stock purchases by a member of its board. The transactions, detailed in a regulatory filing, are often interpreted by investors as a signal of strong confidence in the company's future prospects.
Details of the Transactions
According to a Form 4 filed with the Securities and Exchange Commission (SEC), director Gregory Austin Ciongoli purchased a total of 102,603 shares of Regenxbio's common stock in a series of open-market trades over two days.
- Tuesday: Ciongoli acquired 49,196 shares at a weighted average price of $9.1411 per share.
- Wednesday: An additional 53,407 shares were purchased at a weighted average price of $9.356 per share.
The total value of these purchases exceeded $950,000. Following the transactions, Ciongoli's beneficial ownership in the company increased to 118,035 shares, according to the filing.
AdMarket Significance and Context
Substantial open-market purchases by corporate insiders are closely watched by the market. Unlike stock awards or options exercises, these transactions involve the director's own capital and can indicate a belief that the company's stock is undervalued.
The SEC filing also noted other compensation-related awards for the director. Ciongoli received 15,432 restricted stock units (RSUs) and was granted stock options to purchase 69,609 shares. These are distinct from the open-market purchases that prompted the positive market reaction.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.
Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.
Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.
DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.